ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1129

Development and Validation Of a Rapid Knee Cartilage Quantification Method

Ming Zhang1, Jeffrey B. Driban2, Lori Lyn Price3, Daniel Harper1, Grace H. Lo4, Eric Miller5, Robert J. Ward6 and Timothy E. McAlindon7, 1Rheumotology, Tufts Medical Center, Boston, MA, 2Rheumatology, Tufts Medical Center, Boston, MA, 3Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 4VA HSR&D Center for Innovations in Quality, Effectiveness and Safety; Medical Care Line and Research Care Line; Department of Medicine, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX, 5Department of Electrical and Computer Engineering, Tufts University, Medford, MA, 6Radiology, Tufts Medical Center, Boston, MA, 7Division of Rheumatology, Tufts Medical Center, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: cartilage, measure and osteoarthritis, MRI

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases II: Imaging in Spondyloarthritis and Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Cartilage morphometry on magnetic resonance images (MRIs) may become an acceptable outcome measure for clinical trials among patients with knee osteoarthritis (OA). However, obtaining accurate and reproducible cartilage data is burdensome. To conduct large clinical trials it will be vital to use an efficient, sensitive and reproducible method to assess cartilage morphometry. The purpose of this study was to develop and validate a rapid semi-automated method to detect cartilage loss in the medial tibiofemoral compartment.

Methods: The rapid knee cartilage quantification method was developed using 263 manually-segmented knee MRIs. We designed a pair of two dimensional, rectangular, universal coordinate systems to represent the articular surface of the distal medial femur and proximal medial tibia. Next, we projected segmented cartilage onto coordinate system and evenly selected 9 informative locations across the region most frequently denuded (Figure 1). The primary outcome is a cartilage damage index (CDI), which summates the products of cartilage thickness, cartilage length and voxel size from each informative location. To validate CDI we selected 102 subjects from Osteoarthritis Initiative with a diverse range of Kellgren-Lawrence (KL) grades (0 to 4). 3D Double-echo steady-state sagittal images were obtained on four 3-Tesla systems (0.37 mm x 0.37 mm, 0.7 mm slice thickness). One reader used customized software to measure the CDI in the medial femur and tibia from the baseline and 24-month visit. Another reader evaluated 20 subjects to establish the inter-tester reliability test.

Results: The average measurement time was 14 minutes per pair of knees. The intra-tester reliability (intraclass correlation coefficient ICC [3,1 model] 0.95 to 0.99) and inter-tester reliability (ICC [2,1 model] 0.85 to 0.94) were good. Knees with greater medial joint space narrowing (JSN) had lower mean CDI (i.e. greater loss, Table 1). Knees with radiographic progression (JSN grade change) had 4.5 to 22 times greater CDI loss than knees with no progression (p < 0.0001), Table 2.

Conclusion: This novel knee cartilage damage quantification method is rapid, reliable, and has good construct validity in the medial tibiofemoral compartment. It has utility for deployment in large epidemiological studies.

Table 1. Cartilage damage index stratified by joint space narrowing (JSN) grade

Cartilage Measure

JSN=0 (n=43) mean

JSN=1 (n=25) mean

JSN=2 (n=26) mean

JSN=3 (n=3) mean

p-value

Cross-sectional

Femur CDI (Baseline)

747.95

664.55

521.57

308.95

<0.01

Tibia CDI (Baseline)

389.56

368.12

292.77

149.53

<0.01

Tibiofemoral CDI (Baseline)

1137.50

1032.70

814.34

458.48

<0.01

Longitudinal

Femur CDI (Change)

-2.95

-19.33

-47.15

-99.30

<0.01

Tibia CDI (Change)

-9.31

-26.25

-45.00

-43.86

<0.01

Tibiofemoral CDI (Change)

-12.26

-45.58

-92.15

-143.2

<0.01

Notes: change = follow-up minus baseline; SD = standard deviation

Table 2.Change in cartilage damage index among knees with and without structural progression defined by change in radiographic JSN grade

Cartilage Measure

JSN change

N

Mean

SD

SRM

p-value

Femur CDI (Change)

No change

74

-3.38

47.98

-0.07

<0.0001

Change

25

-66.17

56.76

-1.17

Tibia CDI (Change)

No change

74

-12.85

23.38

-0.55

<0.0001

Change

25

-55.55

39.82

-1.40

Tibiofemoral  CDI (Change)

No change

74

-16.23

56.68

-0.29

<0.0001

Change

25

-121.70

77.17

-1.58

Notes: JSN change, the follow-up has different JSN score with baseline; N = number of knees (the numbers were excluded JSN=3 which is the highest grade); SD = standard deviation; SRM = standard response mean


Disclosure:

M. Zhang,
None;

J. B. Driban,
None;

L. L. Price,
None;

D. Harper,
None;

G. H. Lo,
None;

E. Miller,
None;

R. J. Ward,
None;

T. E. McAlindon,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-and-validation-of-a-rapid-knee-cartilage-quantification-method/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology